Osteoporotic Fracture

Better cardiovascular health significantly reduced the risk for bone fractures related to osteoporosis, according to results from a cross-sectional study.

WASHINGTON — Although even low-dose prednisone significantly increases the risk for fracture in systemic lupus erythematosus, there is no increased risk from intramuscular triamcinolone or intravenous methylprednisolone, said a speaker.

The risk for fractures among postmenopausal women may vary between ethnic origin groups, according to findings from the Women’s Health Initiative published in The Journal of Bone and Mineral Research.

According to published results, cumulative doses of injected corticosteroids were not associated with increased risk of any subsequent fracture or subsequent osteoporotic fracture.

Patients had poor compliance with wearing hyperextension orthoses for nonoperative treatment of osteoporotic vertebral fractures, according to results published in The Spine Journal.

Postmenopausal women with osteoporosis who use denosumab as a first-line therapy have lowers risk for fractures compared with women who use alendronate, according to an industry press release.

Published results showed integration of fracture liaison and orthopedic services, as well as inpatient zoledronic acid administration, may improve osteoporosis pharmacotherapy rates among patients with fragility fractures.

Published results showed older patients who used a wheelchair may have a lower risk for most fractures compared with ambulatory controls.

CHICAGO — Although cement augmentation did not alter the rate of secondary fracture after osteoporotic compression fracture, results presented here showed a decrease in secondary fracture rate with anti-osteoporotic medications.

Published results showed hospitalized bed rest for 2 weeks may reduce the number of patients with osteoporotic vertebral fractures and poor prognostic MRI findings who require surgery.